Edward W Pegg Iii, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1505 Eastland Dr, Suite 2400, Bloomington, IL 61701 Phone: 309-661-7344 Fax: 309-661-7343 |
Asifa Choudhry, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3024 E Empire St Fl 2, Bloomington, IL 61704 Phone: 309-556-7800 Fax: 309-556-7804 |
Barry Jay Riskin, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 2502 E Empire St, Bloomington, IL 61704 Phone: 309-385-7010 |
Dr. Gil B Abelita, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 108 W Market St, Bloomington, IL 61701 Phone: 309-827-5351 Fax: 309-829-6808 |
Brian Compton, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 3024 E Empire St, Bloomington, IL 61704 Phone: 309-556-7500 Fax: 309-556-7804 |
Barbara Luann Weis, FNP BC Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1701 E College Ave, Bloomington, IL 61704 Phone: 309-661-5050 |
Dr. Rhoda Jean Gottfried, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 3024 E Empire St, 2nd Floor Suite A, Bloomington, IL 61704 Phone: 309-556-7800 Fax: 309-556-7804 |
News Archive
University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that's crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.
Implementing lifestyle changes in patients with impaired glucose tolerance has lasting cardiovascular benefits, show findings published in The Lancet Diabetes and Endocrinology.
A preclinical test that may open new perspectives in the diagnosis of neurological disorders. This is the result accomplished by a group of researchers from the Center of Complexity and Biosystems of the University of Milan, who just published their work on 'Physical Review Applied'.
Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by The University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health.
› Verified 7 days ago